The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
from NDTV News - Special https://ift.tt/2EntxSq
Subscribe to:
Post Comments (Atom)
New academic year fuels retailers' sales
Back-to-school shopping season sees a surge in demand for stationery companies like ITC and DOMS, and retailers like Reliance Retail's S...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
No comments:
Post a Comment